MedPath
NMPA Approval

Drospirenone and Ethinylestradiol Tablets

国药准字HJ20220070

August 10, 2022

Drug Information

屈螺酮炔雌醇片

片剂

每片含炔雌醇0.03mg和屈螺酮3mg

化学药品

August 10, 2022

August 9, 2027

Company Information

Applicant Company

Gyömrői út 19-21., Budapest, 1103 , Hungary

Manufacturing Company

Gyömrői út 19-21., Budapest, 1103 , Hungary

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

屈螺酮炔雌醇片 - NMPA 批准文号 | MedPath